C
CRL icon

Certuity’s Charles River Laboratories CRL Stock Holding History

Certuity’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317K Sell
1,398
-131
-9% -$23.3K 0.02% 490
2026
Q1 		$264K Sell
1,529
-50
-3% -$9.27K 0.02% 507
2025
Q4 		$315K Sell
1,579
-53
-3% -$9.61K 0.02% 398
2025
Q3 		$255K Buy
+1,632
New +$259K 0.02% 447

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Certuity's CRL Position: Q2 2026 in Review

Certuity reduced its Charles River Laboratories (CRL) stake by 8.6% in Q2 2026, selling an estimated $23.3K and leaving 1,398 shares worth $317K. The position accounts for 0.02% of the portfolio, ranked #490.

Certuity first reported a position in CRL in Q3 2025 and has held it in 4 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Certuity held 1,398 shares of Charles River Laboratories worth $317K as of Q2 2026.
  • Certuity sold 131 Charles River Laboratories shares in Q2 2026, an estimated $23.3K.
  • Charles River Laboratories made up 0.02% of Certuity's portfolio in Q2 2026, its #490 holding.
  • Certuity first reported a position in Charles River Laboratories in Q3 2025 and has held it in 4 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.